Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01800292 · ClinicalTrials.gov registry record · Phase 4

Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.

A Phase 4 study, sponsored by University of Arizona.

Completed
Registry status
Phase 4
Development phase
9
Enrollment target

NCT01800292 is a Phase 4 study that has completed, run by University of Arizona. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01800292, a Phase 4 study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
Phase 4
Development phase
9 participants
Enrollment target

Study Summary

The purpose of this study is to determine if patients with pulmonary hypertension and mildly elevated heart pressure known as PCWP will exhibit different patterns on echocardiography and that these patterns will predict treatment response to sildenafil, a drug given for this condition.

Interventions

  • DRUG sildenafil

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2013-02
Est. Completion 2014-12
Phase Phase 4

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT01800292

The ClinicalTrials.gov registry entry for NCT01800292 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which sildenafil is the first listed.

NCT01800292 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01800292 about?

NCT01800292 is a clinical study titled "Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.". The purpose of this study is to determine if patients with pulmonary hypertension and mildly elevated heart pressure known as PCWP will exhibit different patterns on echocardiography and that these patterns will predict treatment response to sildenafil, a drug given for this condition.

What is the current status of trial NCT01800292?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2013-02. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01800292?

The interventions under investigation include: sildenafil (DRUG).

Who is sponsoring clinical trial NCT01800292?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.